If you are searching for the best melatonin supplement, you have probably noticed the gummies at your local pharmacy come dosed at 5 or 10 mg per serving, while the studies keep mentioning 0.3 mg.
Quick Answer: which melatonin supplement is actually worth buying?
The 2 to 3 we would actually start with:
- Low-dose immediate-release melatonin, 0.3 to 1 mg, taken 30 to 60 minutes before target bedtime. This matches endogenous secretion physiology and the dose used in most chronobiology trials. Pure Encapsulations 0.5 mg, Life Extension 300 mcg, and Thorne Melaton-3 (splittable) are reasonable when sourced from brands with documented testing.
- Prolonged-release 2 mg melatonin (Circadin or equivalent), only for adults over 55 with primary insomnia and morning awakening complaints. This is the dose and form behind the published prolonged-release evidence.
- A 0.5 mg sublingual liquid for jet lag, dosed at the destination bedtime for 2 to 4 nights after eastbound travel, per the Cochrane review.
Who should NOT start with these: pregnant or nursing individuals (defer to your OBGYN), children and adolescents (pediatric melatonin should be a clinician decision, not a routine consumer choice), and adults with chronic insomnia driven by anxiety, depression, or pain (the AASM recommends CBT-I as first-line). Anyone on SSRIs, especially fluvoxamine, should consult their prescriber because CYP1A2 inhibition can dramatically raise plasma melatonin.
What to do FIRST: before paying for any melatonin, audit sleep hygiene and light exposure. Consistent morning bright-light exposure plus dim evening lighting is the structural circadian intervention; melatonin works downstream and cannot rescue a phone-in-bed routine. For chronic insomnia, the first-line treatment per AASM guidelines is CBT-I, not melatonin.
What melatonin actually is, briefly
Melatonin is an endogenous hormone synthesized from serotonin in the pineal gland under control of the suprachiasmatic nucleus (SCN), the master circadian pacemaker in the hypothalamus. SCN activity is entrained by retinal light input via the retinohypothalamic tract, which is why morning bright light advances the circadian phase and evening blue light delays it. Endogenous secretion begins about 2 hours before habitual sleep onset (the dim light melatonin onset, DLMO), peaks mid-night at roughly 0.1 to 0.3 ng/mL plasma, and returns to baseline by morning.
Exogenous melatonin acts on two G-protein-coupled receptors. MT1 activation suppresses SCN neuronal firing and promotes sleep propensity. MT2 activation drives the phase-shifting effect, which is what makes melatonin useful for circadian rhythm disorders like jet lag and delayed sleep wake phase disorder (DSWPD). Both receptors downregulate under chronic high-dose exposure, which is the mechanistic basis for why supraphysiological dosing produces worse outcomes over time, not better.
A 0.3 mg oral dose produces a plasma peak in the endogenous nighttime range. A 3 mg gummy produces a peak roughly 10 to 30 times higher, sustained for hours past the natural fall-off. The marketing intuition that more is more misreads the receptor biology entirely. The NIH ODS melatonin fact sheet is the cleanest professional summary of the dose-response landscape.
For chronic insomnia, the AASM clinical practice guideline (Sateia et al. 2017) gives melatonin a weak recommendation against first-line use, with CBT-I as first-line. The AASM endorses melatonin specifically for circadian rhythm sleep-wake disorders (DSWPD, jet lag, non-24-hour sleep-wake disorder, shift work disorder), per the Auger et al. 2015 guideline. Most people buying melatonin are using it as a general sleep aid, which is not the indication the strongest evidence supports.
Strong evidence forms: which melatonin format actually delivers
Low-dose immediate-release tablets (0.3 to 1 mg)
Why it helps. Immediate-release dosing produces a sharp plasma peak 30 to 60 minutes after ingestion, mimicking the natural rise that precedes sleep onset. At 0.3 to 1 mg, the peak sits in or just above the endogenous nighttime range, enough to engage MT1 sleep propensity and MT2 phase shift without saturating the receptors or producing a long supraphysiological tail.
What the trials show. The Brzezinski et al. 2005 meta-analysis of 17 RCTs found melatonin reduced sleep onset latency by an average of 4 minutes and increased total sleep time by 13 minutes, modest but consistent. The Auld et al. 2017 systematic review reached similar conclusions: small improvements in sleep latency and quality across primary sleep disorders, with the strongest evidence for circadian indications.
Dose used in trials. The chronobiology literature has consistently shown 0.3 mg produces effects comparable to 3 mg on sleep latency, with less morning grogginess. The dose-response curve flattens early.
Form to look for. A simple immediate-release tablet, ideally splittable. USP Verified or NSF Contents Certified is the floor. Avoid gummies as your primary form because dosing accuracy is the worst in the category and added sugar has its own sleep effects.
Skip if you wake groggy on 0.3 to 1 mg already. Some people are slow metabolizers; dropping below 0.3 mg or using a sublingual drop at 0.2 mg is the next move.
Actionable takeaway: if you are buying your first melatonin and do not have a specific clinical indication, a 0.5 mg immediate-release tablet from a USP Verified brand is the rational starting point. The 5 mg gummy is not.
Prolonged-release tablets (2 mg, adults over 55)
Why it helps. Endogenous melatonin secretion declines with age. Adults over 55 with primary insomnia who complain primarily of middle-of-night and early-morning awakening have the strongest case for a prolonged-release formulation, which produces a slower, longer plasma peak matching the natural overnight profile.
What the trials show. Wade et al. 2010 in BMC Medicine randomized 791 adults over 55 with primary insomnia to 2 mg prolonged-release melatonin or placebo for 3 weeks, with a 6-month extension. The melatonin arm showed improvements in sleep quality and morning alertness, with the largest benefits in the oldest subgroup. The 2 mg formulation is approved in Europe as Circadin and is available OTC in the US under various brand labels.
Dose used in trials. 2 mg prolonged-release, taken 1 to 2 hours before bedtime.
Form to look for. A genuine prolonged-release or biphasic-release tablet labeled as such. "Time release" is a marketing term, not a regulated one.
Skip if you are under 55 with sleep-onset insomnia. Prolonged-release pharmacokinetics suit maintenance, not initiation.
Sublingual liquid or fast-dissolving (0.3 to 1 mg)
Why it helps. Sublingual administration bypasses first-pass hepatic metabolism and produces an even sharper plasma peak than an oral tablet. For jet lag the precisely timed phase shift on a few specific nights is mechanistically useful. A single drop from a 0.5 mg/drop dropper allows 0.2 to 1 mg titration without splitting tablets.
What the trials show. The Herxheimer & Petrie 2002 Cochrane review concluded 0.5 to 5 mg taken at destination bedtime is effective for eastbound travel across 5 or more time zones, with 0.5 mg producing similar benefit to 5 mg. The eastbound effect is stronger because eastward travel requires a phase advance, the direction melatonin promotes most effectively.
Dose used in trials. 0.5 to 5 mg at destination bedtime; the lower end performed as well as the higher.
Form to look for. A glycerin-based sublingual dropper or a true fast-dissolving sublingual tablet (not a capsule held under the tongue, which behaves like an oral dose).
Skip if you have a sensitive gag reflex or strong taste aversion.
Actionable takeaway: match the form to the problem, not the marketing. Immediate-release for onset, prolonged-release for over-55 maintenance, sublingual for jet lag precision.
Moderate evidence forms: where the case is real but smaller
Melatonin plus magnesium glycinate combinations are popular and biologically plausible. Magnesium is a cofactor in melatonin synthesis and acts on GABA-A receptors as a mild allosteric modulator, a different sedation pathway than MT1/MT2. The combo is not synergistic in the strict pharmacological sense; it is two drugs hitting two systems. If you are already low on dietary magnesium, pairing them is reasonable. If you are not, the magnesium is filler at sleep doses. For a focused comparison see our magnesium vs melatonin for sleep deep-dive.
Melatonin plus L-theanine is the other common combo. L-theanine modulates alpha-wave activity and may reduce sleep-onset anxiety in some users; human trial evidence is small. Worth trying for a racing-mind problem at lights-off; not the right framing for a circadian phase delay.
Pediatric melatonin is the most fraught moderate-evidence category. Some evidence supports short-term use in children with neurodevelopmental conditions under specialist supervision, but routine use in neurotypical children is not supported, and accidental pediatric ingestion of high-dose adult gummies is now a major US poison-control concern. Consult the pediatrician, not the Target aisle.
Popular but evidence-thin: the 5 to 10 mg gummy aisle
The dominant US melatonin format is the 5 to 10 mg fruit gummy. A supplement brand can look impressive on a label and still miss the basics of receptor pharmacology; this category is the case in point. The dose is roughly 10 to 30 times physiological, the gummies typically contain added sugar (which disrupts overnight glucose excursions), and a 2017 J Clin Sleep Med analysis by Erland and Saxena found 71% of melatonin products surveyed contained a measured dose outside ±10% of label, with variability ranging from -83% to +478%. The same survey found measurable serotonin in 26% of products.
If you are on a 5 to 10 mg gummy and wake groggy with vivid dreams and flattened sleep architecture, you are reading the receptor downregulation signal the chronobiology literature would have predicted. The fix is not to switch brands at the same dose; drop to 0.3 to 1 mg of a USP Verified immediate-release tablet and watch the morning fog clear in 3 to 5 nights.
What to look for when buying
| Question | What to check |
|---|---|
| Is the per-serving dose 0.3 to 3 mg, not 5 or 10 mg? | Lower-dose products match the chronobiology literature; higher doses match marketing, not biology |
| Is the form right for your problem? | Immediate-release for sleep onset, prolonged-release for adults over 55 with maintenance complaints, sublingual for jet lag precision |
| Is the brand USP Verified, NSF Contents Certified, or ConsumerLab Approved? | The Erland 2017 finding of 71% off-label dosing makes third-party verification non-negotiable in this category |
| Is the product labeled "pharmaceutical grade" or "synthetic" rather than animal-pineal-derived? | Synthetic pharmaceutical-grade melatonin is the standard; animal-derived material has been off the market in regulated supply chains for years but appears in unverified imports |
| Are there other actives in the formulation? | Combos with magnesium glycinate or L-theanine are defensible if dose-matched; combos with kava, valerian, or unspecified herbal blends muddy the dose attribution |
For a deeper framing of how we evaluate brands in this category, see how we review supplements.
When supplements are not enough
Defer the melatonin purchase and prioritize a clinician visit if:
- Insomnia persists for more than 3 months despite consistent sleep hygiene and a low-dose melatonin trial; this is chronic insomnia and AASM guidelines recommend CBT-I before pharmacologic options
- Sleep difficulty is paired with low mood, anhedonia, weight change, or suicidal ideation; treat the underlying mood disorder, and if there is any thought of self-harm contact the 988 Suicide and Crisis Lifeline (US) or your local crisis line immediately
- You snore heavily, wake gasping, or your partner reports breathing pauses; rule out obstructive sleep apnea with a sleep study before any sedative-like intervention
- You are pregnant, nursing, or planning pregnancy; safety data is limited and the decision belongs with your OBGYN
- The patient is a child or adolescent; routine pediatric use is not supported, and a neurodevelopmental indication is a specialist conversation
- You are on fluvoxamine, other SSRIs, warfarin, or sedating medications; melatonin metabolism and additive sedation can produce meaningful interactions and your prescriber should know
The real question is not "which melatonin supplement is best", it is "do I have a circadian problem that melatonin actually addresses, and am I dosing it the way the chronobiology literature suggests rather than the way the marketing suggests."
FAQ
Is more melatonin better?
No. Endogenous nighttime plasma melatonin peaks around 0.1 to 0.3 ng/mL, and a 0.3 mg oral dose produces a peak in roughly that range. A 5 mg gummy produces a peak 10 to 30 times higher, sustained past the natural overnight profile, which over time downregulates MT1 and MT2 receptors and produces morning grogginess and flattened sleep architecture.
Should I take melatonin every night long-term?
Probably not. The cleanest evidence supports melatonin for circadian rhythm disorders (jet lag, DSWPD, shift work adjustment) and short-term primary insomnia in adults over 55. Without a circadian indication the framing should be cyclical (travel or shift transitions, taper off in stable periods), not chronic. Chronic insomnia is a CBT-I problem first per AASM guidelines.
Does melatonin cure insomnia?
No. Melatonin is a circadian-phase tool, not a hypnotic in the benzodiazepine sense. It shifts the timing of sleep propensity; it does not force sleep onto a wound-up nervous system. The Brzezinski meta-analysis found roughly a 4-minute reduction in sleep latency on average. Anyone selling melatonin as a cure for chronic insomnia is selling ahead of the evidence.
Is melatonin safe for kids?
Pediatric melatonin should be a clinician decision, not a routine consumer one. There is some evidence for short-term use in children with neurodevelopmental conditions under specialist supervision, but accidental ingestion of high-dose adult gummies has driven a sharp rise in US pediatric poison-control calls. Talk to the pediatrician.
What about shift work?
Melatonin has a real role in shift-work adjustment, particularly for night-shift workers transitioning back to daytime. The dosing is precise (timed to target sleep onset on the new schedule, often combined with strategic light exposure). For a structured framing see our best supplements for shift workers piece.
Conclusion: the bottom line on best melatonin supplement
The honest summary: melatonin is a circadian-phase tool with a narrow set of well-supported indications (jet lag, DSWPD, shift-work adjustment, adults over 55 with primary insomnia), and a much broader market position as a general sleep aid where the evidence is modest and the standard US dose is 10 to 30 times physiological. The best melatonin supplement for most adults is a 0.3 to 1 mg immediate-release tablet from a USP Verified brand, taken 30 to 60 minutes before target bedtime. Chronic insomnia is a CBT-I problem first per AASM guidelines; melatonin sits adjunctive, not primary, in that workflow.
Next steps:
- Start at the lowest reasonable dose (0.3 to 0.5 mg immediate-release) and titrate up only if you do not get the effect; the dose-response curve flattens early
- Match form to problem (immediate-release for onset, prolonged-release for over-55 maintenance, sublingual for jet lag precision), not whatever is on the front pharmacy shelf
- For related framing see our best supplements for shift workers roundup, our magnesium vs melatonin for sleep head-to-head, and Maria Rodriguez's author page for related neurotransmitter and circadian coverage
Reviewed by Maria Rodriguez, MS Nutrition Science, focused on cognitive and mood biochemistry.
This article is for informational purposes and not medical advice. Melatonin can interact with SSRIs (especially fluvoxamine via CYP1A2 inhibition), warfarin, and other sedating medications, and safety data in pregnancy, lactation, and pediatric populations is limited. Consult a licensed physician or pharmacist before starting any supplement, particularly if you are pregnant, nursing, taking prescription medications, managing a chronic mood or sleep disorder, or considering melatonin for a child. If you are experiencing thoughts of self-harm, contact the 988 Suicide and Crisis Lifeline (US) or your local crisis line immediately.
Recommended Products
As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you. We only recommend products supported by published research or third-party testing.
